Literature DB >> 9186782

Staphylococcal protein A binding to VH3 encoded immunoglobulins.

K N Potter1, Y Li, V Pascual, J D Capra.   

Abstract

Staphylococcal protein A (SPA) is a B-cell superantigen which binds specifically to the variable region of human VH3 encoded antibodies. We undertook to identify the VH3 regions involved in the interaction with SPA by producing mutant antibodies in the baculovirus expression system. We had previously shown that a single amino acid change at position 57 in the CDR2 of a human SPA nonbinding VH3 encoded rheumatoid factor converted it to an SPA binder, implicating CDR2 in SPA binding. When regions of the mutated binder were exchanged with those from a mouse nonbinding antibody, the pattern of SPA binding indicated that residues in FR1, CDR2 and FR3 are involved in the interaction between VH3 encoded antibodies and SPA. In addition, all three regions are simultaneously required for SPA binding to occur. When any one of the three regions was altered, SPA binding was severely disrupted.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186782     DOI: 10.3109/08830189709116521

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  6 in total

1.  Co-evolution of affinity and stability of grafted amyloid-motif domain antibodies.

Authors:  Mark C Julian; Christine C Lee; Kathryn E Tiller; Lilia A Rabia; Evan K Day; Arthur J Schick; Peter M Tessier
Journal:  Protein Eng Des Sel       Date:  2015-09-19       Impact factor: 1.650

2.  Virginia Pascual, MD: a conversation with the editor.

Authors:  Virginia Pascual; William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-01

3.  Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants.

Authors:  A A McCormick; M H Kumagai; K Hanley; T H Turpen; I Hakim; L K Grill; D Tusé; S Levy; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Improving the developability of an anti-EphA2 single-chain variable fragment for nanoparticle targeting.

Authors:  Melissa L Geddie; Neeraj Kohli; Dmitri B Kirpotin; Maja Razlog; Yang Jiao; Tad Kornaga; Rachel Rennard; Lihui Xu; Birgit Schoerberl; James D Marks; Daryl C Drummond; Alexey A Lugovskoy
Journal:  MAbs       Date:  2016-11-17       Impact factor: 5.857

5.  Degradation of C-terminal tag sequences on domain antibodies purified from E. coli supernatant.

Authors:  Simon Lykkemark; Ole Aalund Mandrup; Niels Anton Friis; Peter Kristensen
Journal:  MAbs       Date:  2014       Impact factor: 5.857

6.  Understanding ForteBio's Sensors for High-Throughput Kinetic and Epitope Screening for Purified Antibodies and Yeast Culture Supernatant.

Authors:  Yao Yu; Scott Mitchell; Heather Lynaugh; Michael Brown; R Paul Nobrega; Xiaoyong Zhi; Tingwan Sun; Isabelle Caffry; Yuan Cao; Rong Yang; Irina Burnina; Yingda Xu; Patricia Estep
Journal:  J Biomol Screen       Date:  2015-10-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.